Bournemouth’s win was another low point in Chelsea’s seasonKick-off: 3pm, Saturday 23 April 2016Referee: Roger East (Wiltshire)Match in a nutshell: With just one win in their last seven games in all competitions, Chelsea aim to avenge December’s home defeat by Bournemouth.BetVictor.com preview: Expect Blues to get back to winning waysInjuries and suspensionsAFC BOURNEMOUTHRuled out: Adam Smith (groin), Harry Arter (Achilles), Tyrone Mings (knee).Fitness tests: Benik Afobe (hamstring).CHELSEARuled out: John Terry (Achilles), Kurt Zouma (knee), Loic Remy (groin), Thibaut Courtois (suspended). Possible line-upsAFC Bournemouth: Boruc; Francis, Elphick, Cook, Daniels; Ritchie, Surman, Gosling, Gradel; Stanislas; King.Subs from: Federici, Wiggins, Distin, MacDonald, O’Kane, Pugh, Iturbe, Murray, Afobe, Grabban, Wilson, Rantie.Chelsea: Begovic; Azpilicueta, Cahill, Ivanovic, Baba; Mikel, Fabregas; Willian, Loftus-Cheek, Pedro; Costa. Subs from: Amelia, Blackman, Aina, Miazga, Matic, Colkett, Oscar, Kenedy, Hazard, Falcao, Pato, Traore. Vital statisticsForm guide – last five league matchesAFC Bournemouth total: L W L L W (6 points)Home: L L W W L (6 points)Chelsea total: L L W D D (5 points)Away: L W W W D (10 points)Top scorers – all competitionsAFC Bournemouth: King 7; Stanislas 5, Wilson 5; Afobe 4, Cook 4, Gosling 4, Murray 4, Pugh 4; Daniels 3, Ritchie 3; Smith 2; Arter 1, Gradel 1, Kermorgant 1, MacDonald 1, Tomlin 1.Chelsea: Costa 15; Willian 10; Oscar 8; Pedro 7; Fabregas 5; Traore 4; Cahill 3, Ramires 3, Remy 3; Azpilicueta 2, Hazard 2, Ivanovic 2, Kenedy 2, Loftus-Cheek 2, Zouma 2; Falcao 1, Matic 1, Mikel 1, Pato 1, Terry 1.Last five meetings5 December 2015: Chelsea 0 AFC Bournemouth 14 October 1994: AFC Bournemouth 0 Chelsea 121 September 1994: Chelsea 1 AFC Bournemouth 028 November 1989: AFC Bournemouth 2 Chelsea 325 March 1989: Chelsea 2 AFC Bournemouth 0Chelsea 1 win, Man City 2 wins, 2 drawsFollow West London Sport on TwitterFind us on Facebook
You can get involved with television personality Dr Michael Mol, entrepreneur Emmanuel Bonoko and social cohesion activist Yusuf Abramjee, here:Emmanuel Bonoko, founder of E Bonoko Foundation, is one of the guests on episode eight of the Play Your Part television series, broadcast on 28 October 2017. (Images supplied)Brand South AfricaIn episode eight of the Play Your Part television series you’ll hear how Emmanuel Bonoko uses his companies to run a book drive for youth in impoverished communities. He also holds workshops on entrepreneurship and mentorship.The other two guests are Yusuf Abramjee and Dr Michael Mol. The episode of Play Your Part, which will be aired on Saturday, 28 October, is hosted by musician Kabelo Mabalane.Here’s how you can get involved with the guests and their initiatives:Emmanuel BonokoBonoko’s book drive project was founded in 2012 under the E Bonoko Foundation. The books are delivered to schools in impoverished areas, libraries, prisons and community centres. The entrepreneur also hosts various speakers who give talks on leadership, business and youth empowerment under his company, E Bonoko Holdings.Contact detailsWebsite: ebonokofoundation.co.zaEmail: email@example.comTwitter: @EMMANUELBONOKOYusuf AbramjeeYusuf AbramjeeAbramjee was Primedia’s Lead SA ambassador, a campaign that spreads news of South Africans doing great work to make the country a better place. This Play Your Part ambassador is involved with several non-governmental organisations. He is also the director of Crime Stoppers International, as well as ambassador of initiatives such as the CEO Sleepout South Africa and #TurnBackCrime.Contact detailsWebsite: abramjee.comEmail: firstname.lastname@example.orgTwitter: @AbramjeeDr Michael MolDr. Michael MolMol found a way to give every South African access to a doctor via their cellphones by using mobile technology. His passion for medicine also led to two television series, Hello Doctor and The Dr Michael Mol Show, which he produces.Contact detailsWebsite: drmichaelmol.comEmail: email@example.comTwitter: @drmichaelmolPlay Your Part is broadcast at 18:00 on Saturdays on SABC 2.To get involved in playing your part in South Africa:Check out the conversation on Twitter: #GetInvolved; orFind out about initiatives on Play Your Part here.Tell us how you Play Your Part through our social media channels:Follow us on Twitter: @PlayYourPartSA;Follow Brand South Africa on Twitter: @Brand_SA;Like us on Facebook: Official Brand South Africa.Would you like to use this article in your publication or on your website? See Using Brand South Africa material.
By spring of last year, manufactured-home specialist Clayton Homes had formally rolled out its i-House line of modular homes, whose basic $75,000 model features one bedroom and one bath in 723 sq. ft.There’s also a 1,023-sq.-ft. two-bedroom version that starts at about $94,000, and buyers looking for yet more space can prep their building site for a Flex Room – a detached 268-sq.-ft. module with a full bath and a deck but no bedroom or kitchen, for about $30,000.With its trailer-like shape, concrete-fiber and metal siding, and metal butterfly roof, the i-House iresembles many of the simple, easily transported homes that have competed in the Solar Decathlon in Washington, D.C. The i-House roof and floor are insulated to R-30 and the exterior walls to R-21. (We’re awaiting word from the manufacturer for details about airtightness.)A debut in GeorgiaWe were reminded of Clayton’s i-House ambitions by a recent Jetson Green post highlighting an open-house event at Green Bridge Farm, an organic farm that includes a 9-lot housing community on 25 acres in Guyton, Georgia, not far from Savannah. The centerpiece of the open house is an i-House, designed to operate at net zero energy, and an adjacent Flex Room. It is one of the first residences built in the development, where lots of 1.2 to 1.6 acres sell for between $50,000 and $55,000 apiece.Except for Denver, Colorado, the i-House hasn’t made it to many climates in the U.S. where the snow load and cold in winter can be severe. And as noted in a blog post on its website, i-House doesn’t meet code in certain states, including Michigan, although it is available in some parts of Canada.According to the website, i-Houses are currently, or will soon be, installed in 10 locations in the U.S.: Fredericksburg, Virginia; Raleigh, North Carolina; Charleston, South Carolina; Savannah, Georgia; Knoxville, Tennessee; Denver, Colorado; Albuquerque, New Mexico; Tucson, Arizona; Sacramento, California; and Bend, Oregon.
Officials from the communities that host Travis Air Force Base in northern California are considering several projects to support the installation.Under one proposal, Solano County would issue bonds to finance the construction of a civil engineering facility that would allow the base to consolidate more than 50 scattered engineering operations and buildings, reported the Daily Republic. A new facility would make the base more efficient and free up space needed for flight operations, said Vacaville Mayor Len Augustine, who traveled to Washington, D.C., last week with colleagues from Fairfield and the county to promote Travis on Capitol Hill and at the Pentagon.The budget for the project, which does not yet have a specific timeline, is between $20 million and $30 million, Augustine said.“Our plan is we want to move forward with the base as quickly as possible,” said David White, city manager for Fairfield.The delegation also discussed plans to develop a 70-acre parcel under the Air Force Community Partnership Program. The plan is intended to provide a new source of revenue for the installation through a lease for the property.“Nothing is on paper, so anything is possible,” Augustine said. “But I don’t think it would be housing. It would more likely be commercial and maybe some light industrial.”The delegation also discussed efforts to secure a more reliable water source for Travis. With several of the base’s existing sources expected to end, the installation intends to develop more groundwater sources. At the same time, Travis is discussing the possibility of obtaining a secondary water source from Fairfield or Vacaville, according to the story. Dan Cohen AUTHOR
Meghan MarkleGetty ImagesMeghan Markle may not have been the Queen’s favourite after all. Though the Queen is gracious and cordial to the Duchess of Sussex when they are in public, it seems that the Queen’s affection is all for the cameras.According to the claims of a documentary, the “grandmotherly love” the monarch showed could have been a PR exercise. Being part of the Royal Family comes with its own set of advantages and disadvantages, one of these disadvantages being that the members of the Royal Family are always under the scrutiny of the media. Meghan Markle has been a part of the Royal Family only for a little while, which makes her a novice in Royalty’s public relations.The Queen, on the other hand, is a veteran at handling and presenting a Royal image to the world. Now according to reports, the Queen and Meghan Markle have an amicable relationship where Meghan apparently refers to the monarch as “Mama” in private. However, according to the documentary “Harry and Meghan: the first 100 days”, the Queen’s warm behaviour could be a PR exercise by the Palace. Meghan MarkleGetty ImagesMeghan Markle has been on the Queen’s radar for a while now, especially with reports of a Royal feud brewing between the Duchesses of Cambridge and Sussex. The Queen tamped down any attempt by Meghan to separate herself from the Royal family and to carve out her own path.But it seems that the Queen could be making an effort with Meghan Markle as the Palace may not want a repeat of what happened with Princess Diana. Either way, it seems the Queen and the Duchess of Sussex have many opportunities to work on their relationship. Meghan Markle is expected to give birth this month and the couple Sussex will be moving to Frogmore cottage after the arrival of the baby.
India’s largest drug-maker Sun Pharmaceutical Industries Ltd reported a 30% slump in quarterly profit on Saturday, 7 November, as sales in most of its markets fell and costs related to fixing compliance issues continued to hurt.In the company’s largest market, the United States, Sun Pharma’s sales in the quarter ended September were down 28%, which the company attributed mainly to increasing competition and a supply crunch at its Halol manufacturing plant in India.”Halol” was a key contributor to Sun Pharma’s sales, but in September, the US Food and Drug Administration (FDA) outlined a number of problems with manufacturing processes, and the company has since been working on remediating those.However, its profit has been hit for a few quarters as it had to restrict supply, and has not been getting US approvals to launch any product made at the Halol plant.The company’s Managing Director Dilip Shanghvi sought to assure analysts on a conference call on Saturday evening that remediation efforts were on track, though they aren’t yet complete, so the USFDA has not been invited for a re-inspection.”We are keeping (the FDA) updated on the progress at the agreed frequency. I think the things we have promised or assured the FDA, we are addressing,” he said. The company has not received any feedback from the FDA, he added.Halol is one of several Sun Pharma plants undergoing remediation. Five of its other plants â€” most of which it got as part of its acquisition of Ranbaxy Laboratories Ltd last year â€” are under an FDA import ban ever since the agency found a series of quality control issues at the plants.Shanghvi said the “full value” of the Ranbaxy deal would be realised by 2018.Apart from generics, the company is developing a drug to treat “psoriasis”, which is in Phase 3 clinical trials and expected to be filed for US approval in 2017.Sun Pharma reported a July-September net profit of Rs 1,107 crore ($167.4 million), down from Rs 1,572 crore a year earlier. Analysts, on average, were expecting Rs 1,308 crore, according to Thomson Reuters data.Total revenue was down 15% as sales across the countries it operates in fell. India was the only exception, where sales rose a marginal 1%.The company said currency volatilities and a decision to reduce its presence in some less-profitable areas hurt its sales in emerging and other markets during the quarter.